Replies to post #3618 on Galectin Therapeutics Inc. (GALT)

[mikeslife]

Thanks for your insight. You sound like a really cool guy!

[stock_observer_77]

LOL $1 - $2

[Amatuer17]

This is long term play if they go alone - I am expecting a partnership or BO as they possibly run the trial alone.

500 patients -11 countries - 128 sites
12-14 month enrollment + 24 months from last patients for results - results in 2022
no interim readout
Very long road and only $44 million on hand

On other hand only Phase 3 NASH-CX trial on horizon - in reality only NASH-CX product to talk about.

My hope and expectation is - One of the top BP - BMY-MRK-PFE-Gild can just pay $50-100 million and lock them into collaboration

The only other P3 independent target is MDGL - trial started with end date 2024. The mc is $1.50 Billion + but it is in NASH-FX where few more BP players

So hoping that once protocol is approved - we may see collaboration and SP does not go below $2.50

[Minitruckin]

Can you pm what you think phil expect pps will be, in send over your phone number

[Minitruckin]

Any update on ph where you been